Taxane induced neuropathy in patients affected by breast cancer: Literature review.

Francesca De Iuliis, Ludovica Taglieri, Gerardo Salerno, Rosina Lanza, Susanna Scarpa

Journal: Critical reviews in oncology/hematology 2016;96(1):34-45

PMID: 26004917

Full Text on Elsevier Science View on PubMed

Abstract

Taxane induced neuropathy (TIN) is the most limiting side effect of taxane based chemotherapy, relative to the majority of breast cancer patients undergoing therapy with both docetaxel and paclitaxel. The symptoms begin symmetrically from the toes, because the tips of the longest nerves are affected for first. The patients report sensory symptoms such as paresthesia, dysesthesia, numbness, electric shock-like sensation, motor impairment and neuropathic pain. There is a great inter-individual variability among breast cancer women treated with taxanes, in fact 20-30% of them don't develop neurotoxicity. Actually, there is no standard therapy for TIN, although many medications, antioxidants and natural substances have been tested in vitro and in vivo. We will summarize all most recent literature data on TIN prevention and treatment, in order to reach an improvement in TIN management. Further studies are needed to evaluate new therapies that restore neuronal function and improve life quality of patients.

Address: Experimental Medicine Department, Sapienza University, viale Regina Elena 324, 00161 Rome, Italy.; Ginecology and Obstetrics Department, Sapienza University, viale Regina Elena 324, 00161 Rome, Italy.; Experimental Medicine Department, Sapienza University, viale Regina Elena 324, 00161 Rome, Italy. Electronic address: [email protected].

DOI: 10.1016/j.critrevonc.2015.04.011

Link outs

Free resources

Medical:

https://medlineplus.gov/breastcancer.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Antineoplastic Agents, Phytogenic, Antioxidants, Breast Neoplasms, Economics, Pharmaceutical, Female, Humans, Neuroprotective Agents, Neurotoxicity Syndromes, Taxoids